Tuesday, October 10, 2017

Breast cancer news

The most striking breast cancer news were introduced by British scientific team from University of Manchester, UK. Clinical study showed that the combination of two drugs Lapatinib (Tyverb) and Trastuzumab (Herceptin) is significantly shrinking certain breast cancer tumors. This shrinkage occurs only 11 days after diagnosis. It should be mentioned that lapatinib and trastuzumab are not new – both drugs are commonly used in breast cancer treatment already, but this is the first time they had been combined together and used before surgery and chemotherapy. Actually, the way that they are being used in combination with each other is new – they were able to eliminate some types of breast cancer in just 11 days.
Discover ALL about 11 days breast cancer treatment in ...

No comments: